Impact of serum alkaline phosphatase level on the pathophysiologic mechanism of contrast-induced nephropathy

Kardiologia Polska

Volumn 72, Issue 10, 2014, Pages 977-982

  Karabulut, Ahmet ^a   Sahin, Irfan ^b   Avci, Ilhan Ilker ^b   Okuyan, Ertugrul ^b   Dogan, Zeki ^a   Uzunlar, Bulent ^a   Cakmak, Mahmut ^a   Gurdogan, Muhammet ^c  

^a Istanbul Medicine Hospital   (Turkey)

^b Bagcilar Education and Research Hospital   (Turkey)

^c Private Kesan Hospital Department of Cardiology   (Turkey)

Author keywords

Alkaline phosphatase; Contrast induced nephropathy; Pathophysiology

Indexed keywords

CREATININE; PHOSPHATE; URIC ACID; ALKALINE PHOSPHATASE; CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; ACUTE KIDNEY FAILURE; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; PERCUTANEOUS CORONARY INTERVENTION;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; ALKALINE PHOSPHATASE; CONTRAST MEDIA; FEMALE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES;

EID: 84911123990     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.a2014.0072     Document Type: Article

References (25)

1. Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis, 2011; 4: 85-99.
2. Nough H, Eghbal F, Soltani M et al. Incidence and main determinants of contrast-induced nephropathy following coronary angiography or subsequent balloon angioplasty. Cardiorenal Med, 2013 ;3: 128-135.
3. Alharazy SM, Kong N, Saidin R et al. Serum neutrophil gelatinase-associated lipocalin and cystatin c are early biomarkers of contrastinduced nephropathy after coronary angiography in patients with chronic kidney disease. Angiology, 2014; 65: 436-442.
4. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant, 2013; 28: 254-273.
5. Demirkol S, Balta S, Akgul EO et al. Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention. Clinics (Sao Paulo), 2013; 68: 1071.
6. Boyacioglu M, Turgut H, Akgullu C et al. The efficient of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rat. J Vet Med Sci, 2014; 76: 1-8.
7. Huang SS, Huang PH, Leu HB et al. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention. J Hypertens, 2013; 31: 2187-2194.
8. Wannamethee SG, Sattar N, Papcosta O et al. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol, 2013; 33: 1070-1076.
9. Park JB, Kang DY, Yang HM et al. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. Eur Heart J, 2013; 34: 920-931.
10. Tonelli M, Curhan G, Pfeffer M et al. Relation between alkaline phosphatase, serum phosphate, and allcause or cardiovascular mortality. Circulation, 2009; 120: 1784-1792.
11. Schoppet M, Shanahan CM. Role for alkaline phosphatase as an inducer of vascular calcification in renal failure? Kidney Int, 2008; 73: 989-991.
12. Magnusson P, Sharp CA, Magnusson M et al. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int, 2001; 60: 257-265.
13. Schmid H, Mall A, Bockhorn H. Catalytic activities of alkaline phosphatase and N-acetyl-beta-D-glucosaminidase in human cortical nephron segments: heterogeneous changes in acute renal failure and acute rejection following kidney allotransplantation. J Clin Chem Clin Biochem, 1986; 24: 961-970.
14. De Carvalho JA, Piva SJ, Hausen BS et al. Assessment of urinary gamma-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy. Clin Chim Acta, 2011; 412: 1407-1411.
15. Nuyts GD, Yaqoob M, Nouwen EJ et al. Human urinary intestinal alkaline phosphatase as an indicator of S3-segment-specific alterations in incipient diabetic nephropathy. Nephrol Dial Transplant, 1994; 9: 377-381.
16. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. a cohort analysis. JAMA, 1996; 275: 1489-1494.
17. Deray G. Nephrotoxicity of contrast media. Nephrol Dial Transplant, 1999; 14: 2602-2260.
18. Katholi RE, Woods WT Jr, Taylor GJ et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis, 1998; 32: 64-71.
19. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int, 1992; 41: 1408-1415.
20. Cantley LG, Spokes K, Clark B et al. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int, 1993; 44: 1217-1223.
21. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res, 2006; 99: 1044-1059.
22. Regidor DL, Kovesdy CP, Mehrotra R et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol, 2008; 19: 2193-2203.
23. Detrano R, Guerci AD, Carr JJ et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med, 2008; 358: 1336-1345.
24. Shanahan CM, Cary NR, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation, 1999; 100: 2168-2176.
25. Leibovitch I, Ben-Chaim J, Ramon J, Goldwasser B. Increased serum alkaline phosphatase activity: a possible indicator of renal damage. J Clin Lab Anal, 1991; 5: 406-409.